Ebola outbreak expands in the Democratic Republic of the Congo as oral-drug trial begins
The largest Ebola outbreak is expanding in the Democratic Republic of the Congo, with a reported 48% crude fatality rate. A clinical trial of oral drug NV-387 is scheduled to begin next week.
By DoomRadar · Published on DoomRadar .
Why it matters
Continued expansion of a high-fatality Ebola outbreak creates a serious public-health risk and could increase transmission beyond affected areas.
Related source links
These links were collected with this event. Recorded source dates may reflect when a link was found. Article publication dates are shown only when available from the source. Open the originals for their full context.
- Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in DR Congo with 48% Crude Fatality Rate, Says NanoViricides ↗tennesseedaily.com · Recorded source date: Sep 15, 2026, 2:31 PM UTC
- Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in DR Congo with 48% Crude Fatality Rate, Says NanoViricides ↗newjerseytelegraph.com · Recorded source date: Sep 15, 2026, 3:17 PM UTC
- Ebola outbreak in DR Congo tops 6,600 cases ↗cidrap.umn.edu · Recorded source date: Sep 16, 2026, 12:02 AM UTC
AI-assisted, source-based analysis. Methodology · Report a correction